Pulse Biosciences
PLSE
49 hedge funds and large institutions have $47.4M invested in Pulse Biosciences in 2017 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 9 increasing their positions, 8 reducing their positions, and 8 closing their positions.
433% more capital invested
Capital invested by funds: $8.89M → $47.4M (+$38.5M)
263% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 8
69% more funds holding
Funds holding: 29 → 49 (+20)
13% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 8
6.6% more ownership
Funds ownership: 3.08% → 9.69% (+6.6%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$12.1M |
| 2 |
State Street
Boston,
Massachusetts
|
+$3.61M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.44M |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$2.4M |
| 5 |
Wells Fargo
San Francisco,
California
|
+$1.48M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Cadence Capital Management
Boston,
Massachusetts
|
-$506K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$455K |
| 3 |
JAM
JW Asset Management
Miami Beach,
Florida
|
-$448K |
| 4 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$286K |
| 5 |
Millennium Management
New York
|
-$244K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TC
51
TFS Capital
West Chester,
Pennsylvania
| – | -$286K | -14,019 | Closed |
|
|
52
Millennium Management
New York
| – | -$244K | -11,975 | Closed |
|
53
Jane Street
New York
| – | -$243K | -11,908 | Closed |
|
|
LCS
54
Levin Capital Strategies
New York
| – | -$204K | -10,000 | Closed |
|
|
SCM
55
Segantii Capital Management
Hong Kong
| – | -$165K | -8,100 | Closed |
|
56
Bank of Montreal
Toronto,
Ontario, Canada
| – | -$41K | -2,000 | Closed |
|
|
FMA
57
FNY Managed Accounts
New York
| – | -$20K | -1,001 | Closed |
|
PLSE Hedge Fund Activity: Q2 2017 in Review
49 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Pulse Biosciences (PLSE) for Q2 2017, worth a combined $47.4M — up 433% from $8.89M a quarter earlier.
Buyers outnumbered sellers: 29 funds opened new PLSE positions and 8 closed out — a net gain of 21 holders — while 9 added to existing stakes and 8 trimmed.
The largest buyer was BlackRock, adding an estimated $12.1M. The largest seller was Cadence Capital Management, cutting an estimated $506K.
- 49 institutional investors held Pulse Biosciences (PLSE) as of Q2 2017, up from 29 in Q1 2017.
- Funds reported $47.4M of Pulse Biosciences stock for Q2 2017, up 433% quarter-over-quarter.
- 29 funds opened new Pulse Biosciences positions in Q2 2017 and 8 closed out, a net change of +21 holders.
- The largest Pulse Biosciences buyer in Q2 2017 was BlackRock, an estimated $12.1M added.
- The largest Pulse Biosciences seller in Q2 2017 was Cadence Capital Management, an estimated $506K sold.
Based on aggregated 13F filings for Q2 2017.